Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Clinical trial NCT04541277 · UNKNOWN

Trial details

NCT number: NCT04541277
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapsed or Refractory Acute Myeloid Leukemia, Elderly, Unfit Acute Myeloid Leukemia With Positive Minimal Residual Disease

Start date: 2020-09-01
Primary completion: 2021-08-30
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.